REVIEWING THE LATEST PRECLINICAL PROGRESS OF NOVEL ALS TARGETS - 3rd ALS Drug Development Summit

Skip to content

Returning May 2025

View Upcoming Events in the CNS Series

Home
About
What’s On
- 2024 Full Event Guide
- 2024 Speakers
Partnership
- Partnership Opportunities
- 2024 Partners
Take Part
- Register Interest
- Contact us

REVIEWING THE LATEST PRECLINICAL PROGRESS OF NOVEL ALS TARGETS

Time: 10:50 am
day: Day Two Track A AM

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

Scroll To Top

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok